 Long-acting GLP-1 receptor agonist injections are more effective at reducing HbA1c levels in diabetes patients than gliptins when added to metformin, say European researchers. |
 Educating patients to self-manage their diabetes has little effect long-term on their lifestyle choices or their health outcomes, concludes a major UK study. |
 GPs are being urged to ramp up diabetes treatment within just three months if they do not reach their glycaemic goals on metformin alone, under a radical update of guidelines issued by European and American diabetes societies. |
 HbA1c levels rise rapidly in the year before a diagnosis of type 2 diabetes, say Japanese researchers. |
 Although metformin is the ‘gold standard’ treatment for diabetes, it has little effect on reducing the risk of death or cardiovascular disease, say the authors of two new analyses. |
 A comment by the mother of this patient led Dr Keith Hopcroft to the right diagnosis |
|
This award-winning photograph shows a diabetic cataract. |
|
Dr Simon Clay looks at how to code patients with diabetes, CKD or both |
|
Dr Mary Pierce and Dr Stephanie Baldeweg’s tips on spotting, treating and following-up women who develop diabetes during pregnancy |
|
Endocrinologist Dr Colin Johnston answers GP Dr David Morris’s questions |
 Overzealous enforcement and pointless target chasing is harming patients, says Dr Clive Henderson |
|
Moving the target from 7% to 7.5% may see some patients miss out on best care, says Dr Martin Hadley-Brown. But Dr Richard Lehman argues that the 7% target should never have been introduced and it is right to scrap it |
|
GPs often complain about the Government’s one-size-fits-all approach to policy and funding. By Gareth Iacobucci looks at the unique challenges faced by a large urban practice and a small rural one |
|
|
|
A Tardis of a book - small on the outside, but packed full of evidence-based information about diabetes |
|
The new diabetes targets may not be achievable, will be too aggressive and won't target those at highest risk, warns Dr Martin Hadley-Brown. But Dr Jonathan Graffy argues that by setting targets across a range of blood sugars, the indicators will extend benefits to more patients and drive improvement |
|
A journalist who has lived with diabetes for 35 years gives her take on how to live with - and take control of - the illness |
|
An Australian book, which only partly makes the transition for a UK audience |